Furthermore, TCGA data indicated that increased mRNA expression of PJA1 was associated with markedly reduced overall survival of patients with HCC, suggesting that high activity of PJA1 may confer a poor HCC prognosis. Here, PJA1 is linked to hepatocellular carcinoma.